Cargando…
Metabolic reprogramming heterogeneity in chronic kidney disease
Fibrosis driven by excessive accumulation of extracellular matrix (ECM) is the hallmark of chronic kidney disease (CKD). Myofibroblasts, which are the cells responsible for ECM production, are activated by cross talk with injured proximal tubule and immune cells. Emerging evidence suggests that alte...
Autores principales: | Miguel, Verónica, Kramann, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315765/ https://www.ncbi.nlm.nih.gov/pubmed/36723270 http://dx.doi.org/10.1002/2211-5463.13568 |
Ejemplares similares
-
Cardiac Remodeling in Chronic Kidney Disease
por: Kaesler, Nadine, et al.
Publicado: (2020) -
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
por: Li, Yin, et al.
Publicado: (2021) -
Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism
por: Hsu, Chien-Ning, et al.
Publicado: (2020) -
Macrophage metabolic reprogramming during chronic lung disease
por: Ogger, Patricia P., et al.
Publicado: (2020) -
Reprogramming Metabolism of Macrophages as a Target for Kidney Dysfunction Treatment in Autoimmune Diseases
por: Tian, Feng, et al.
Publicado: (2022)